Comments

Soleno Therapeutics

SLNONASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$46.96
00.00%
Pre-Market: Jul 19, 4:00 PM EDT
15 minutes delayed
Soleno Therapeutics (SLNO) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Outperform
Highest Price Target1
$93.00
Lowest Price Target1
$35.00
Consensus Price Target1
$60.33

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Soleno Therapeutics (NASDAQ:SLNO) Stock, Analyst Ratings, Price Targets, Forecasts

Soleno Therapeutics Inc has a consensus price target of $60.33 based on the ratings of 6 analysts. The high is $93 issued by Piper Sandler on February 5, 2024. The low is $35 issued by Cantor Fitzgerald on September 26, 2023. The 3 most-recent analyst ratings were released by Oppenheimer, Baird, and Piper Sandler on May 13, 2024, May 10, 2024, and February 5, 2024, respectively. With an average price target of $74.67 between Oppenheimer, Baird, and Piper Sandler, there's an implied 59.00% upside for Soleno Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Jan
1
Feb
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Oppenheimer
Baird
Piper Sandler
Stifel
Guggenheim

1calculated from analyst ratings

Analyst Ratings for Soleno Therapeutics

Buy NowGet Alert
05/13/2024Buy Now25.64%Oppenheimer
Leland Gershell
$65 → $59MaintainsOutperformGet Alert
05/10/2024Buy Now53.32%Baird
Brian Skorney
 → $72Initiates → OutperformGet Alert
02/05/2024Buy Now98.04%Piper Sandler
Yasmeen Rahimi
 → $93Initiates → OverweightGet Alert
01/23/2024Buy Now34.16%Stifel
Dae Gon Ha
 → $63Initiates → BuyGet Alert
01/02/2024Buy Now0.09%Oppenheimer
Leland Gershell
$44 → $47MaintainsOutperformGet Alert
11/21/2023Buy Now-14.82%Guggenheim
Debjit Chattopadhyay
 → $40Assumes → BuyGet Alert
09/26/2023Buy Now-25.47%Cantor Fitzgerald
Kristen Kluska
$19 → $35MaintainsOverweightGet Alert
09/15/2023Buy Now-70.19%Oppenheimer
Leland Gershell
$8 → $14MaintainsOutperformGet Alert
08/31/2023Buy Now-59.54%Cantor Fitzgerald
Kristen Kluska
 → $19ReiteratesOverweight → OverweightGet Alert
07/11/2023Buy Now-59.54%Cantor Fitzgerald
Kristen Kluska
 → $19Initiates → OverweightGet Alert
05/25/2023Buy Now-82.96%Oppenheimer
Leland Gershell
 → $8Reiterates → OutperformGet Alert
03/24/2023Buy Now-82.96%Oppenheimer
Leland Gershell
 → $8Reiterates → OutperformGet Alert

FAQ

Q

What is the target price for Soleno Therapeutics (SLNO) stock?

A

The latest price target for Soleno Therapeutics (NASDAQ:SLNO) was reported by Oppenheimer on May 13, 2024. The analyst firm set a price target for $59.00 expecting SLNO to rise to within 12 months (a possible 25.64% upside). 9 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Soleno Therapeutics (SLNO)?

A

The latest analyst rating for Soleno Therapeutics (NASDAQ:SLNO) was provided by Oppenheimer, and Soleno Therapeutics maintained their outperform rating.

Q

When was the last upgrade for Soleno Therapeutics (SLNO)?

A

There is no last upgrade for Soleno Therapeutics

Q

When was the last downgrade for Soleno Therapeutics (SLNO)?

A

There is no last downgrade for Soleno Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Soleno Therapeutics (SLNO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Soleno Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Soleno Therapeutics was filed on May 13, 2024 so you should expect the next rating to be made available sometime around May 13, 2025.

Q

Is the Analyst Rating Soleno Therapeutics (SLNO) correct?

A

While ratings are subjective and will change, the latest Soleno Therapeutics (SLNO) rating was a maintained with a price target of $65.00 to $59.00. The current price Soleno Therapeutics (SLNO) is trading at is $46.96, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch